Relapsed Marginal Zone Lymphoma
1 clinical trials · Condition
◉ Watch Relapsed Marginal Zone Lymphoma
| Record | Firm | Date |
|---|---|---|
| A Study of BGB-21447, a Bcl-2 Inhibitor, in Mature B-Cell Malignancies (NCT05828589) | BeOne Medicines | 2023-06-20 |
Track Relapsed Marginal Zone Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.